The Use of Aromatherapy for Symptom Management
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this pilot study is to introduce the use of aromatherapy/essential oils to medical oncology patients at Central DuPage Hospital to assess their perceived effectiveness to relieve symptoms of nausea or vomiting and/or anxiety. Peppermint oil will be used for nausea/vomiting and lavender oil will be used for anxiety. This study will involve administration of aromatherapy to a convenience sample of patients, who will then be asked to complete a brief questionnaire. The questionnaire will involve a simple likert scale to measure efficacy (in the opinion of the patient) and simple multiple-choice questions to determine patients' likeliness to use aromatherapy again.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2014
CompletedFirst Posted
Study publicly available on registry
June 13, 2014
CompletedStudy Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedFebruary 4, 2015
February 1, 2015
11 months
June 11, 2014
February 3, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Post Intervention Patient Interview Form
24hrs post aromatherapy
Study Arms (1)
Peppermint and Lavender Essential Oils
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Adult hospitalized medical oncology patients admitted to Central DuPage Hospital.
- Age 18 years or greater.
- Able to understand and speak English.
- Women of non-childbearing potential or with childbearing potential with a negative pregnancy test documented during the hospital stay.
- Able to understand concept of aromatherapy for treatment of distressing symptoms.
You may not qualify if:
- Prisoners.
- Non-English speaking patients.
- Under the age of 18.
- Unable to comprehend the concept of aromatherapy.
- Severe cognitive impairment.
- Not experiencing the symptoms of nausea, vomiting or anxiety.
- Women with child-bearing potential who have not had a negative pregnancy test during the hospital stay.
- Patients with known allergy to lavender or peppermint.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Central DuPage Hospital
Winfield, Illinois, 60190, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Lyons, MSN, APN/CNS, RN-BC, ONC
Central DuPage Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 11, 2014
First Posted
June 13, 2014
Study Start
July 1, 2014
Primary Completion
June 1, 2015
Last Updated
February 4, 2015
Record last verified: 2015-02